<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00313547</url>
  </required_header>
  <id_info>
    <org_study_id>MHI 05740</org_study_id>
    <secondary_id>Pfizer NRA9060008</secondary_id>
    <secondary_id>(Investigator initiated study)</secondary_id>
    <nct_id>NCT00313547</nct_id>
  </id_info>
  <brief_title>High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine in the Treatment of High-Risk Hypertensive Patients</brief_title>
  <official_title>Impact of High-Dose Quinapril Versus Low-Dose Quinapril Plus Amlodipine on Autonomic Regulation and on Sympathetic Activation in Response to Cold Exposure in Hypertensive Patients With Impaired Glucose Tolerance, Diabetes or Coronary Artery Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Montreal Heart Institute</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Pfizer</agency>
      <agency_class>Industry</agency_class>
    </collaborator>
  </sponsors>
  <source>Montreal Heart Institute</source>
  <brief_summary>
    <textblock>
      The purpose of this study is to compare the impact of two blood pressure lowering treatments
      (high dose quinapril versus low dose quinapril plus amlodipine) on variations in heart rate
      over 24 hours.
    </textblock>
  </brief_summary>
  <overall_status>Terminated</overall_status>
  <why_stopped>
    Very difficult to recruit patients/slow recruitment(2 patients in nearly 2 years).
  </why_stopped>
  <start_date>April 2006</start_date>
  <completion_date type="Actual">March 2008</completion_date>
  <primary_completion_date type="Actual">April 2007</primary_completion_date>
  <phase>Phase 4</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Crossover Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Heart rate variability</measure>
  </primary_outcome>
  <secondary_outcome>
    <measure>Tolerability</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Renin, aldosterone</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>MMPs</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Oxidative stress</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Norepinephrine</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Lactate</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Exercise tolerance at 20 and -8 degree celsius</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Blood pressure</measure>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Impact of selected pharmacogenetic polymorphisms</measure>
  </secondary_outcome>
  <enrollment type="Anticipated">40</enrollment>
  <condition>Hypertension</condition>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Quinapril 40 mg</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Drug</intervention_type>
    <intervention_name>Quinapril 10 mg and amlodipine 5 mg</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Patients with a documented history of hypertension defined as: SBP &gt; or = 140 mmHg or
             DBP &gt; or = 90 mmHg if hypertension untreated or patients currently treated for
             hypertension.

          -  Documented CAD or diabetes or impaired glucose tolerance

          -  Sinus rhythm

        Principal Exclusion Criteria:

          -  Previous intolerance or allergic reaction to an ACE inhibitor, an ARB or
             dihydropyridine calcium channel blocker

          -  History of angioedema or cough related to previous ACE inhibitor use.

          -  Systolic blood pressure &gt; 180 mmHg or diastolic blood pressure &gt; 110 mmHg in untreated
             patients

          -  Systolic blood pressure &gt; 160 mmHg or diastolic blood pressure &gt; 100 mmHg in patients
             currently treated by an ACE inhibitor or an ARB

          -  Creatinine clearance &lt; 30 ml/min

          -  Significant liver dysfunction

          -  Current serum potassium &gt; or = 5 mmol/L or a history of marked ACE inhibitor or ARB
             induced hyperkalemia resulting in either a serum potassium &gt; or = 5.5 mmol/L or a
             life-threatening adverse event.

          -  History of HF or known LVEF &lt; or = 45%

          -  Bilateral renal artery stenosis (or unilateral if only one kidney)

          -  Unstable angina, myocardial infarction or coronary revascularization within the last 3
             months.

          -  Connective tissue disease or chronic inflammatory condition

          -  Active malignancy

          -  Active infection in the last 2 weeks

          -  Inability or any contraindication to perform an exercise test.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michel White, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Montreal Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Simon de Denus, B. Pharm, MSc</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Pharmacy, University of Montreal/Montreal Heart Institute</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacques de Champlain, MD, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Faculty of Medicine, University of Montreal</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Montreal Heart Institute</name>
      <address>
        <city>Montreal</city>
        <state>Quebec</state>
        <zip>H1T 1C8</zip>
        <country>Canada</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Canada</country>
  </location_countries>
  <verification_date>August 2007</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>April 10, 2006</study_first_submitted>
  <study_first_submitted_qc>April 11, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">April 12, 2006</study_first_posted>
  <last_update_submitted>May 2, 2008</last_update_submitted>
  <last_update_submitted_qc>May 2, 2008</last_update_submitted_qc>
  <last_update_posted type="Estimate">May 6, 2008</last_update_posted>
  <keyword>Blood pressure</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Renin</keyword>
  <keyword>Aldosterone</keyword>
  <keyword>Heart rate variability</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Quinapril</mesh_term>
    <mesh_term>Amlodipine</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

